Topics

‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
1 in 6 Germans Experienced COVID Vaccine Side Effects, Survey Finds
A case of fatal multi-organ inflammation following COVID-19 vaccination
A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19
A Closer Look at N1-methylpseudouridinein the Modified mRNA Injectables
A Finnish Survey of Adverse Effects of COVID-19 Injectables and the Functionality of the Medical System
A GMO Experiment on Two-Thirds of the World’s Population: Reaction to Ulrich’s Commentary on Lee and Broudy
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
A Potential Role of the Spike Protein in Neurodegenerative Diseases: A Narrative Review
A Report on the U.S. Vaccine Adverse Events Reporting System (VAERS) of the COVID-19 Messenger Ribonucleic Acid (mRNA) Biologicals
Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning
Abstract 10712: Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines
Acute transverse myelitis after BNT162b2 vaccination against COVID-19: Report of a fatal case and review of the literature
Adjuvant Activity and Toxicological Risks of Lipid Nanoparticles Contained in the COVID-19 “mRNA Vaccines"
Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines
All Cause Mortality and COVID-19 Injections: Evidence from 28 Weeks of Public Health England “COVID-19 Vaccine Surveillance Reports”
Alternate mechanisms of mRNA vaccine toxicity: which one is the main culprit?
An autopsy case report of fulminant myocarditis: Following mRNA COVID-19 vaccination
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
Anaphylaxis-Induced Acute Coronary Syndrome Following Covid-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches
Anti- SARS-CoV-2 Receptor Binding Domain Antibody Evolution after mRNA Vaccination
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections
Assessment of cardiac adverse events following COVID‑19 vaccination by speckle tracking echocardiography
At Least 55 Undeclared Chemical Elements Found in COVID-19 Vaccines from AstraZeneca, CanSino, Moderna, Pfizer, Sinopharm and Sputnik V, with PreciseICP-MS1
Autoimmune and Neoplastic Outcomes After the mRNA Vaccination: The Role of T Regulatory Cell Responses
Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose
Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine in the United States
Biodistribution of mRNA COVID-19 vaccines in human breast milk
BioNTech RNA-Based COVID-19 Injections Contain Large Amounts Of Residual DNA Including An SV40 Promoter/Enhancer Sequence
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Cancer geneticist on the integration of DNA from Covid vaccines into the human genome
Cardiac Adverse Reactions With COVID-19 Vaccinations
Cardiac side effects of RNA-based SARS-CoV-2 vaccines: Hidden cardiotoxic effects of mRNA-1273 and BNT162b2 on ventricular myocyte function and structure
Cardiopulmonary Arrest After COVID-19 Vaccination: A Case Report
Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
Cause Unknown: The Epidemic of Sudden Deaths in 2021 & 2022 & 2023
CDC Finally Released Its VAERS Safety Monitoring Analyses for COVID Vaccines via FOIA
CDC REMOVES Their Claim That mRNA & Spike Protein "Do Not Last Long In The Body”
Chemical-physical criticality and toxicological potential of lipid nanomaterials contained in a COVID-19 mRNA vaccine
Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis
Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis
Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study
Clinical Research into Central Nervous System Inflammatory Demyelinating Diseases Related to COVID-19 Vaccines
Commentary from Dr. David Bauer of the Francis Crick Institute
Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures
Correspondence: Myocarditis after Covid-19 mRNA Vaccination
COVID Vaccine Autopsy Reports: Shocking Impact Revealed
547